214 related articles for article (PubMed ID: 38238581)
21. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
Liu T; Wang Y; Li Z; Sun L; Yang K; Chen J; Han X; Qi L; Zhou X; Wang P
Heliyon; 2023 Nov; 9(11):e21285. PubMed ID: 38027812
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF).
Ye X; Tuo Z; Chen K; Wu R; Wang J; Yu Q; Ye L; Miyamoto A; Yoo KH; Zhang C; Wei W; Li D; Feng D
Oncol Res; 2024; 32(3):503-515. PubMed ID: 38361753
[TBL] [Abstract][Full Text] [Related]
23. 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.
Zhang J; Wang N; Wu J; Gao X; Zhao H; Liu Z; Yan X; Dong J; Wang F; Ba Y; Ma S; Jin J; Du J; Ji H; Hu S
Front Immunol; 2022; 13():844778. PubMed ID: 35309316
[TBL] [Abstract][Full Text] [Related]
24. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
[TBL] [Abstract][Full Text] [Related]
25. NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization.
Zhao Z; Zhou Y; Lv P; Zhou T; Liu H; Xie Y; Wu Z; Wang X; Zhao H; Zheng J; Jiang X
Cancer Lett; 2024 Jun; ():217059. PubMed ID: 38876383
[TBL] [Abstract][Full Text] [Related]
26. 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia.
Ding Y; Bajpai AK; Wu F; Lu W; Xu L; Mao J; Li Q; Pan Q; Lu L; Wang X
Aging (Albany NY); 2024 Jan; 16(3):2340-2361. PubMed ID: 38277218
[TBL] [Abstract][Full Text] [Related]
27. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
28. Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy.
Wu S; Li M; Su R; Shen H; He Y; Zhou Y
Front Surg; 2022; 9():948371. PubMed ID: 36684288
[TBL] [Abstract][Full Text] [Related]
29. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues.
Zhang Q; Zheng Q; Yu X; He Y; Guo W
J Transl Med; 2020 Jun; 18(1):245. PubMed ID: 32571340
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of 5-Methylcytosine Profiles of Messenger RNA in Human High-Grade Serous Ovarian Cancer by MeRIP Sequencing.
Meng L; Zhang Q; Huang X
Cancer Manag Res; 2021; 13():6005-6018. PubMed ID: 34377020
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of key m5C modification-related genes in type 2 diabetes.
Song Y; Jiang Y; Shi L; He C; Zhang W; Xu Z; Yang M; Xu Y
Front Genet; 2022; 13():1015879. PubMed ID: 36276976
[No Abstract] [Full Text] [Related]
32. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
[TBL] [Abstract][Full Text] [Related]
33. Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer.
Huang Z; Li J; Chen J; Chen D
Front Genet; 2021; 12():748279. PubMed ID: 34777473
[No Abstract] [Full Text] [Related]
34. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
[TBL] [Abstract][Full Text] [Related]
35. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
Geng Q; Wei Q; Shen Z; Zheng Y; Wang L; Xue W; Li L; Zhao J
Cancer Manag Res; 2021; 13():7989-8002. PubMed ID: 34707405
[TBL] [Abstract][Full Text] [Related]
37. Exploring the importance of m5c in the diagnosis and subtype classification of COPD using the GEO database.
Wu J; Li X; Kong D; Zheng X; Du W; Zhang Y; Jiao Y; Li X
Gene; 2024 Feb; 895():147987. PubMed ID: 37972696
[TBL] [Abstract][Full Text] [Related]
38. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
[TBL] [Abstract][Full Text] [Related]
40. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
